---
title: 'Director, Market Research, Competitive Intelligence & Forecasting at Definium Therapeutics'
canonical: 'https://feeny.ai/job/director-market-research-competitive-intelligence-forecasting-definium-5rs3dqpfqnkw'
type: 'job'
last_seen: '2026-11-10'
---

# Director, Market Research, Competitive Intelligence & Forecasting at Definium Therapeutics

- **Company:** Definium Therapeutics
- **Location:** Remote
- **Compensation:** $195k–$290k
- **Work type:** remote
- **Posted:** 2026-11-06
- **Last confirmed live:** 2026-11-10
- **Apply:** https://job-boards.greenhouse.io/definiumtherapeutics/jobs/6251391004

## Job description

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!

The Director, Market Research, Competitive Intelligence & Forecasting will lead the development of market insights, competitive intelligence, and commercial forecasts that inform Definium Therapeutics’ commercial strategy, portfolio planning, launch readiness, and long range business planning. The individual will own the integrated process for understanding the market, anticipating competitive change, and translating evidence into patient-based demand and revenue forecasts. This role will partner closely with Finance, Marketing, Market Access, Medical Affairs, Clinical Development, and senior leadership and will manage the functional budget and external partners for market research, competitive intelligence, and forecasting.

Responsibilities:

- Own the integrated market research, competitive intelligence, and forecasting strategy for assigned assets and indications
- Develop and execute primary market research across healthcare professionals, patients, caregivers, payers, and health systems to address priority business questions
- Integrate primary research with epidemiology, claims, electronic health record, prescription, payer, and other secondary data to generate actionable insights
- Lead competitive intelligence monitoring and assess clinical, regulatory, scientific, access, and commercial developments that may affect strategy or market opportunity
- Own patient-based demand and revenue forecasts, including transparent assumptions, data sources, model documentation, and governance
- Lead Long-Range Planning, budget, Latest Estimate, and forecast-update cycles in partnership with Finance and Commercial leadership
- Develop base, upside, downside, and strategic scenarios, with sensitivity analyses that quantify key risks, opportunities, and forecast drivers
- Translate research and competitive developments into implications for market assumptions, launch strategy, portfolio decisions, and investment priorities
- Communicate insights, forecast outputs, risks, opportunities, and recommendations through concise, executive-ready materials for senior leadership and the Board
- Manage market research agencies, forecasting consultants, competitive intelligence partners, data providers, functional budgets, and internal knowledge repositories

Qualifications:

Required:

- Bachelor’s degree in business, life sciences, economics, analytics, statistics, public health, marketing, or a related discipline.
- Minimum 8 years of progressive pharmaceutical or biotechnology experience across market research, competitive intelligence, forecasting, commercial analytics, business insights, or related disciplines
- Demonstrated experience independently developing or managing pharmaceutical patient-based demand and/or revenue forecasts
- Experience with Long-Range Planning, annual budget, Latest Estimate, forecast updates, scenario modeling, and sensitivity analysis
- Demonstrated experience designing and executing primary market research and integrating findings with secondary data and quantitative analytics
- Strong understanding of the U.S. pharmaceutical commercialization process and healthcare environment
- Experience with claims, electronic health records, prescription data, epidemiology, payer/access data, and competitive intelligence sources
- Experience managing external vendors, projects, and functional budgets
- Ability to travel up to 10% by air and/or car, including occasional overnight travel

Preferred:

- Advanced degree in business, life sciences, economics, analytics, public health, or a related field
- Experience in psychiatry, neuroscience, specialty therapeutics, or another complex specialty market
- Experience forecasting a pre-launch asset through commercialization, including launch uptake and longer-term demand scenarios
- Experience supporting product launch, indication expansion, lifecycle strategy, or portfolio evaluation
- Experience integrating primary research, epidemiology, claims, competitive intelligence, analogs, and financial assumptions into commercial forecasts
- Experience establishing or evolving a market insights, competitive intelligence, and/or forecasting capability within a small or mid-sized biotechnology company
- Experience presenting market insights and forecasts to senior leadership or executive decision-making forums
- Familiarity with modern forecasting, analytics, visualization, and AI-enabled insight tools

Individual compensation within the range is determined based on factors such as relevant skills, experience, qualifications, scope of the role, and other legitimate business considerations.  In addition to base salary, this role may be eligible for bonus and equity opportunities. We also offer a comprehensive benefits package including health insurance, 401(k) with company match, flexible time off and additional wellness benefits and perks.  Learn more about our benefits on our Careers page.

The anticipated base salary range for this position is: $195,000—$290,000 USD

## About Definium Therapeutics

## Company Overview
- **One-liner**: Definium Therapeutics is a clinical-stage biopharmaceutical company applying scientific rigor to psychedelic medicine to develop accessible treatments for psychiatric disorders.
- **Entity Type**: Public (NASDAQ: DFTX)
- **Headquarters**: Not specified in available sources; the company operates as a remote-first organization.
- **Founded**: 2019 (originally as MindMed)
- **Founders**: Not publicly available in provided sources.

## Core Business
- **Primary Industry**: Biotechnology / Psychiatric drug development (psychedelic medicine)
- **Target Customers**: Patients with major depressive disorder (MDD), generalized anxiety disorder (GAD), posttraumatic stress disorder (PTSD), and autism spectrum disorder (ASD); also healthcare providers and payers.
- **Mission/Purpose**: “Unlock healing at scale” by harnessing the full therapeutic potential of psychedelic medicine through precise, evidence-based science.

## Products & Services
- **DT120 ODT (Lysergide/LSD D-Tartrate Oral Disintegrating Tablet)**: Investigational drug for GAD, MDD, and PTSD. Currently in four Phase 3 trials (Voyage, Panorama, Emerge, Ascend) and a fifth planned for PTSD. FDA Breakthrough Therapy Designation for GAD. No adjunctive psychotherapy required.
- **DT402 (R(-)-MDMA)**: R-enantiomer of MDMA selected for serotonergic properties with a potentially superior tolerability profile. In Phase 2a study for social communication challenges in autism spectrum disorder.

## Market Standing
- **Valuation/Market Cap**: Not publicly available (publicly listed on NASDAQ as DFTX as of 2026, but recent market cap not provided in search results).
- **Key Metric**: Pre-revenue clinical-stage company; total funding history not disclosed in available sources.
- **Notable Investors/Partners**: Not disclosed in provided sources.
- **Growth Signals**:
  - Five Phase 3 trials ongoing or planned for DT120 ODT.
  - FDA Breakthrough Therapy Designation for DT120 in GAD.
  - Phase 2a trial initiated for DT402 in ASD.
  - Full results from Phase 2b GAD trial published in JAMA (2025).
  - Strong intellectual property with issued patents covering formulation, manufacturing, and treatment.

## Competitive Advantages
- **Proprietary Formulations**: Pharmaceutically optimized ODT for LSD (DT120) and novel R-enantiomer of MDMA (DT402) with potential improved tolerability.
- **Scientific Rigor**: Standalone drug studies without psychotherapy, enabling clearer efficacy and safety data.
- **Regulatory Momentum**: FDA Breakthrough Therapy Designation and multiple IND clearances.
- **Experienced Management Team**: Proven track record in developing and commercializing CNS therapies.
- **Comprehensive IP Strategy**: Patents covering drug formulations, methods of manufacture, and treatment use.

## Strategic Focus
- **Late-Stage Pipeline Advancement**: Completing Phase 3 trials for GAD and MDD, initiating PTSD trial.
- **Pipeline Expansion**: Advancing DT402 for ASD and exploring additional neuropsychiatric indications.
- **Commercial Readiness**: Building infrastructure (hiring VP of Sales, Senior Director of Field VEOR, etc.) to support potential future launch.
- **Data Generation**: Generating high-quality evidence to support regulatory submissions and differentiation.

## Why Work Here
- **Remote-First Culture**: “You can live anywhere in the country you’re employed in” (remote-first workforce).
- **Comprehensive Benefits**: 100% paid medical, dental, vision for employees and dependents; FSA/HSA; life and disability insurance.
- **Wellness & Time Off**: Annual wellness allowance, flexible PTO, company-wide shutdowns for rest.
- **Family Support**: Paid parental leave for birthing and non-birthing parents, 2-week return-to-work transition.
- **Financial Wellness**: Competitive compensation, 401(k) with employer match, employee equity (new hire grants and refreshes), Employee Stock Purchase Plan (ESPP) with discount.
- **Mission-Driven Work**: Opportunity to contribute to groundbreaking treatments in psychedelic psychiatry with a science-driven, collaborative team.

## Sources
1. [definiumtx.com](https://definiumtx.com/) – Company overview and pipeline details
2. [definiumtx.com](https://definiumtx.com/story/) – Company history, leadership, and strategic milestones
3. [definiumtx.com](https://definiumtx.com/careers/) – Careers page with benefits and remote-first policy
4. [definiumtx.com](https://definiumtx.com/research-development/) – Research and development pipeline details
5. [linkedin.com](https://www.linkedin.com/company/definiumtherapeutics) – LinkedIn company page

## Other roles at Definium Therapeutics

- [Director, Medical Marketing](https://feeny.ai/job/director-medical-marketing-definium-therapeutics-remote-mc5tpawqn5hb)
- [Director, Tax](https://feeny.ai/job/director-tax-definium-therapeutics-remote-3p6021vsf7fs)
- [Regional Director, Site Engagement & Access](https://feeny.ai/job/regional-director-site-engagement-access-definium-therapeutics-remote-svpfzm9r0a9n)
- [Director, Medical Information](https://feeny.ai/job/director-medical-information-definium-therapeutics-remote-scwvv7cx6eas)
- [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-definium-therapeutics-remote-wvrjhsw19grb)
- [Associate Director, Brand Counsel](https://feeny.ai/job/associate-director-brand-counsel-definium-therapeutics-remote-drzwb505czfs)
- [Director, Field Operations](https://feeny.ai/job/director-field-operations-definium-therapeutics-remote-03sqbsdm57aa)
- [Manager, Data & Analytics](https://feeny.ai/job/manager-data-analytics-definium-therapeutics-remote-1myd7q4ncfyq)
- [Sr. Director, Sales Training](https://feeny.ai/job/sr-director-sales-training-definium-therapeutics-remote-4e05xqacax1x)
- [Associate Director, Statistical Programming](https://feeny.ai/job/associate-director-statistical-programming-definium-therapeutics-remote-32hes91t3fd9)